2015 ICD-9-CM Diagnosis Code 258.01
Multiple endocrine neoplasia [MEN] type I
- 2015
- Billable Thru Sept 30/2015
- Non-Billable On/After Oct 1/2015
- ICD-9-CM 258.01 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 258.01 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM:
258.01 converts directly to:
- 2015/16 ICD-10-CM E31.21 Multiple endocrine neoplasia [MEN] type I
Approximate Synonyms
- Multiple endocrine neoplasia syndrome
- Multiple endocrine neoplasia type 1
- Multiple endocrine neoplasia, type 1
- Multiple endocrine neoplasm type 1
- Polyglandular activity in multiple endocrine adenomatosis
Clinical Information
- A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the parathyroid glands, the pituitary gland, and the pancreatic islets. The resulting clinical signs include hyperparathyroidism; hypercalcemia; hyperprolactinemia; cushing disease; gastrinoma; and zollinger-ellison syndrome. This disease is due to loss-of-function of the men1 gene, a tumor suppressor gene (genes, tumor suppressor) on chromosome 11 (locus: 11q13)
- A rare, inherited disorder that affects the endocrine glands and can cause tumors in the parathyroid and pituitary glands and the pancreas. These tumors are usually benign (not cancer). They cause the glands to secrete high levels of hormones, which can lead to other medical problems, such as kidney stones, fertility problems, and severe ulcers. In some cases, tumors inside the pancreas can become malignant (cancer)
- Multiple endocrine neoplasia caused by inactivation of the tumor suppressor gene men-1. Patients may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors
Wermer's 258.01
multiple
